Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
The Mechanism of Steroid Hormones in Non-Small Cell Lung Cancer: From Molecular Signaling to Clinical Application
Yao Wang1, Ying Zhou2, Yao Yao1
1Department of Pharmacy, Women's Hospital School of Medicine, Zhejiang University, Hangzhou 310006, China.
Abstract:
Steroid hormones play critical roles in the development and progression of NSCLC through both genomic and non-genomic pathways. This review summarizes the expression profiles and molecular functions of estrogen, progesterone, androgen, and glucocorticoid receptors in NSCLC. Estrogen and progesterone receptors exhibit gender-specific prognostic significance, while glucocorticoid receptors influence tumor growth and immune responses. Emerging evidence supports the use of anti-estrogen therapies and glucocorticoids as adjuncts to existing treatment strategies, including immunotherapy. The crosstalk between hormone signaling and oncogenic pathways such as EGFR or immune checkpoints offers opportunities for novel combination therapies. However, challenges remain in biomarker development, drug resistance, and managing the dual effects of glucocorticoids. A deeper understanding of hormone-tumor-immune interactions is essential to optimize hormone-targeted interventions in NSCLC.
Insights
Steroid hormones significantly impact non-small cell lung cancer (NSCLC) development. Targeting hormone receptors offers potential for novel NSCLC combination therapies, particularly with immunotherapy.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Steroid hormones are implicated in non-small cell lung cancer (NSCLC) progression via genomic and non-genomic mechanisms.
- Key steroid hormone receptors (estrogen, progesterone, androgen, glucocorticoid) are expressed in NSCLC, influencing tumor behavior.
Purpose of the Study:
- To review the expression, molecular functions, and therapeutic implications of steroid hormone receptors in NSCLC.
- To explore the potential of hormone-targeted therapies and their interactions with existing treatments like immunotherapy.
Main Methods:
- Comprehensive literature review of studies on steroid hormone receptors in NSCLC.
- Analysis of expression profiles, functional roles, and clinical significance of these receptors.
- Examination of therapeutic strategies involving hormone modulation and combination treatments.
Main Results:
- Estrogen and progesterone receptors show gender-specific prognostic value in NSCLC.
- Glucocorticoid receptors affect NSCLC tumor growth and modulate immune responses.
- Hormone signaling crosstalks with oncogenic pathways (e.g., EGFR) and immune checkpoints.
Conclusions:
- Anti-estrogen therapies and glucocorticoids show promise as adjuncts to NSCLC treatments, including immunotherapy.
- Targeting hormone-tumor-immune interactions presents opportunities for novel combination therapies in NSCLC.
- Further research is needed to overcome challenges in biomarker development, drug resistance, and glucocorticoid management for optimized interventions.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Related Concept Videos
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Signal Transduction: Overview
Typically, signal transduction involves three...
Endocrine Signaling
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Internal Receptors